A version of this story first ran in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
WASHINGTON — The Food and Drug Administration appears poised to release a long-awaited enforcement policy on cannabidiol, the marijuana-adjacent compound it has struggled to regulate for over a year.
About the Author Reprints
